According to GlobalData’s medical device pipeline database, 417 Spinal Surgery devices are in various stages of development globally. GlobalData’s report Spinal Surgery provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 157 are in active development, while the remaining 263 are in an inactive stage of development. There are 87 products in the early stages of development, and the remaining 70 are in the late stages of development.
Spinal surgery includes devices used in the surgical treatment of degenerative disc diseases, intra-vertebral fractures and scoliosis. Spinal procedures that do not involve usage of spinal fusion or spinal non-fusion devices, such as discectomy, foraminotomy, laminectomy and other procedures, are not included in this model. This model only tracks devices used in spinal fusion procedures.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Spinal Surgery pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Spinal Surgery devices. Overall, most of these Spinal Surgery pipeline devices are being developed by private entities.
Key players involved in the active development of Spinal Surgery include Implanet, University of Toledo, SeaSpine, University of South Florida, SpineSmith Holdings, SINTX Technologies, Alphatec, Medtronic, SpineGuard and Stryker.
For a complete picture of the developmental pipeline for Spinal Surgery devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.